GeneTex

Quality Antibodies, Quality Results

GeneTex creates reagents for biomedical research, assay development, and in vitro diagnostics. Its products are made to standards outlined in quality management systems ISO 9001:2015 and ISO 13485:2016.

Led by the distinguished Dr. Eva Lee, GeneTex has established state-of-the-art facilities in both the United States and Taiwan to provide top-quality antibodies and reagents generated through refined product development programs, international collaborations with leading researchers, and scrupulous scientific rigor. Their mission: “ We strive to serve and accelerate life science research by creating essential biomedical reagents where quality can be found in every vial. ”

Antibody Technology

While commercial polyclonal and monoclonal antibodies have driven progress in science and medicine since their introduction, the generation of reliable antibodies remains an essential goal in the quest for data accuracy and reproducibility. On the forefront of high-quality antibody manufacturing, GeneTex has successfully incorporated recombinant monoclonal antibody technology into its product development platform. This technology has numerous well-documented advantages, with consistency of performance being of paramount significance. GeneTex’s capability in this area enhances its position in the research community and the biotechnology industry and spearheads its efforts to provide the most trusted antibody products available.

Our commitment, to provide our customers with reliable reagents and to drive life science research, reflects the philosophy and approach we employ when we create our products.

Using meticulous manufacturing procedures and stringent testing, we have produced and validated a comprehensive collection of antibodies and research tools that researchers use every day to expand biomedical knowledge.

Product Reliability, Application Performance, and Enhanced Validation

With a 25-year production history, GeneTex continues to distinguish itself by emphasizing reagent validation. Poorly characterized antibodies remain an industry-wide challenge that impacts progress in the life sciences and biomedicine.

At GeneTex, product reliability is our primary concern. Stringent protocols have been established to validate our antibodies for various applications, including WB, IP, IHC, ICC/IF, FACS, and ELISA, using cell lines with known target protein expression levels and a diverse array of tissue samples. Lot-to-lot antibody performance is maintained through a combination of fully characterized reference lots, clone verification, and thorough quality control.

KO/KD validated Founded by scientists for scientists, we at GeneTex understand that researchers expect and demand product fidelity. With that in mind, we are increasingly incorporating more Knockout/Knockdown (KO/KD) validation testing into our quality assurance (QA) regimen. KO/KD testing is a major pillar of our enhanced “Five-Pillar validation” program with the goal of demonstrating to our customers that the GeneTex reagents they purchase are worthy of their trust.